Global Flu RNA Vaccines Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Table of Content

1. Executive Summary
   1. Global Flu RNA Vaccines Market Snapshot, 2026 and 2033
   2. Market Opportunity Assessment, 2025 – 2033, US$ Bn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors – Relevance and Impact
3. Value Added Insights
   1. Vaccine Type Adoption Analysis
   2. Pipeline Assessment
   3. Regulatory Landscape
   4. Value Chain Analysis
   5. Key Deals and Mergers
   6. PESTLE Analysis
   7. Porter’s Five Force Analysis
4. Global Flu RNA Vaccines Market Outlook:
   1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2024
      2. Market Size (US$ Bn) Analysis and Forecast, 2026–2033
   3. Global Flu RNA Vaccines Market Outlook: Vaccine Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Vaccine Type, 2020 – 2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Vaccine Type, 2025 – 2033
         1. Non‑replicating mRNA
         2. Self‑replicating mRNA
         3. Dendritic cell mRNA
         4. Others
      4. Market Attractiveness Analysis: Vaccine Type
   4. Global Flu RNA Vaccines Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End User, 2020 – 2024
      3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2033
         1. Hospitals
         2. Vaccination centers
         3. Clinics
         4. Pharmacies
      4. Market Attractiveness Analysis: End User
5. Global Flu RNA Vaccines Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Region, 2020 – 2024
   3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025 – 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Flu RNA Vaccines Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2024
      1. By Country
      2. By Vaccine Type
      3. By End User
   3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2033
      1. U.S.
      2. Canada
   4. Market Size (US$ Bn) Analysis and Forecast, By Vaccine Type, 2025 – 2033
      1. Non‑replicating mRNA
      2. Self‑replicating mRNA
      3. Dendritic cell mRNA
      4. Others
   5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2033
      1. Hospitals
      2. Vaccination centers
      3. Clinics
      4. Pharmacies
   6. Market Attractiveness Analysis
7. Europe Flu RNA Vaccines Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2024
      1. By Country
      2. By Vaccine Type
      3. By End User
   3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Market Size (US$ Bn) Analysis and Forecast, By Vaccine Type, 2025 – 2033
      1. Non‑replicating mRNA
      2. Self‑replicating mRNA
      3. Dendritic cell mRNA
      4. Others
   5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2033
      1. Hospitals
      2. Vaccination centers
      3. Clinics
      4. Pharmacies
   6. Market Attractiveness Analysis
8. East Asia Flu RNA Vaccines Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2024
      1. By Country
      2. By Vaccine Type
      3. By End User
   3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2033
      1. China
      2. Japan
      3. South Korea
   4. Market Size (US$ Bn) Analysis and Forecast, By Vaccine Type, 2025 – 2033
      1. Non‑replicating mRNA
      2. Self‑replicating mRNA
      3. Dendritic cell mRNA
      4. Others
   5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2033
      1. Hospitals
      2. Vaccination centers
      3. Clinics
      4. Pharmacies
   6. Market Attractiveness Analysis
9. South Asia & Oceania Flu RNA Vaccines Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2024
      1. By Country
      2. By Vaccine Type
      3. By End User
   3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Market Size (US$ Bn) Analysis and Forecast, By Vaccine Type, 2025 – 2033
      1. Non‑replicating mRNA
      2. Self‑replicating mRNA
      3. Dendritic cell mRNA
      4. Others
   5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2033
      1. Hospitals
      2. Vaccination centers
      3. Clinics
      4. Pharmacies
   6. Market Attractiveness Analysis
10. Latin America Flu RNA Vaccines Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2024
       1. By Country
       2. By Vaccine Type
       3. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2033
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Market Size (US$ Bn) Analysis and Forecast, By Vaccine Type, 2025 – 2033
       1. Non‑replicating mRNA
       2. Self‑replicating mRNA
       3. Dendritic cell mRNA
       4. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2033
       1. Hospitals
       2. Vaccination centers
       3. Clinics
       4. Pharmacies
    6. Market Attractiveness Analysis
11. Middle East & Africa Flu RNA Vaccines Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2024
       1. By Country
       2. By Vaccine Type
       3. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2033
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) Analysis and Forecast, By Vaccine Type, 2025 – 2033
       1. Non‑replicating mRNA
       2. Self‑replicating mRNA
       3. Dendritic cell mRNA
       4. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2033
       1. Hospitals
       2. Vaccination centers
       3. Clinics
       4. Pharmacies
    6. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
       1. Moderna, Inc.
          1. Overview
          2. Segments and Products
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Pfizer Inc.
       3. BioNTech SE
       4. Sanofi S.A.
       5. GlaxoSmithKline plc (GSK)
       6. CureVac N.V.
       7. Novavax, Inc.
       8. CSL Limited / Seqirus
       9. Arcturus Therapeutics
       10. Sinovac Biotech Ltd.
       11. Others
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations